Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial

Volume: 145, Issue: 6
Published: Jun 1, 2020
Abstract
BACKGROUND AND OBJECTIVES: There are no US Food and Drug Administration–approved therapies for neonatal seizures. Phenobarbital and phenytoin frequently fail to control seizures. There are concerns about the safety of seizure medications in the developing brain. Levetiracetam has proven efficacy and an excellent safety profile in older patients; therefore, there is great interest in its use in neonates. However, randomized studies have not been...
Paper Details
Title
Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial
Published Date
Jun 1, 2020
Journal
Volume
145
Issue
6
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.